European Technology Platform for Global Animal Health

1
European Technology Platform for Global Animal
Health

• Implementation Plan
• Presentation to Steering Council
• Jim Scudamore
• 6 July 2006

2
ETP Global Animal HealthImplementation plan

• 1. Introduction
• 2. Developing the implementation plan
• 3. Implementation Groups

3
ETP Global Animal HealthImplementation plan

• 1. Introduction
• 2. Developing the implementation plan
• 3. Implementation Groups

4
European Technology Platform for Global Animal
HealthWhere are we now?
Stakeholders, led by industry, come together
to agree on a common vision for the technology
Stakeholders, define a Strategic Research
Agenda setting the necessary mid- to longterm
objectives
Stakeholders, implement the Strategic
Research Agenda with the mobilisation of
significant human and financial resources
Implementation Plan detailed, roadmap,
quantify, identify funding sources creation of a
financial working group Launch late 2006
Vision paper EU TP Global Animal Health
Final version August 2005
Strategic Research Agenda Published May 2006
5
ETP Global Animal HealthThe Vision
Developed by a group of representatives from the
different stakeholders Industry Animal Health,
Biotech, Agriculture Academia Veterinary
Organisations Farmers organizations Consumer
organizations Experts in regulatory issues The
ETPGAH presents Long term vision for the control
of animal diseases of major importance.
Published August 2005
6
ETP Global Animal HealthThe Vision Aim

• To facilitate and accelerate the development and
  distribution of the most effective tools for
  controlling animal diseases of major importance
  to Europe and the rest of the world, thereby
  improving human and animal health, food safety
  and quality, animal welfare, and market access,
  contributing to achieving the Millennium
  Development Goals.

7
ETP Global Animal HealthThe Strategic Research
Agenda

• Following publication of the interim Vision
  Paper, the Steering Council of the ETPGFAH
  decided that 3 workshops should be held to
  address the key issues
• Sought wide spectrum participation of
  stakeholders 20 for each
• Held three 1 day workshops in October and again
  in November 2005 one on each key subject area
• Had designated chairpersons from Steering
  Council

Published May 2006
8
Presentation of the SRA to the Commissioner on 19
May
9
ETP Global Animal HealthWhat are the objectives
of the SRA?

• The SRA is the mechanism to deliver the vision.
• SRA has 2 overarching objectives-
• to deliver new and improved tools for the control
  of major diseases and
• to deliver the recommendations in the SRA which
  in turn will facilitate the development and
  delivery of new tools

10
ETP Global Animal HealthThe SRA Six Themes

• Strategically important issues
• High societal relevance
• Linked to Europes future growth,
  competitiveness, and sustainability
• Dependant upon major research and
  technological advances
• Medium to long-term scope
• Important consequences for animal health
  research
• Aligned with other Community policies and
  strategies
• Significance for developing world

1 Prioritise animal diseases
5 Regulatory Societal Issues
2 Gap Analysis
3 Fundamental research
4 Improve Technology Transfer
6 Global Perspective
SRA
Finalised and submitted to the EU Commission in
May 2006
11
ETP Global Animal HealthThe SRA 6 Themes/61
Recommendations

• Prioritise animal diseases (8)
• Conduct gap analyses (8)
• Ensure high quality relevant (5)
  fundamental research
• Identify the enabling factors to improve the rate
  of technology transfer (17)
• Consider regulatory/societal issues (18)
• Maintain a global perspective (5)

12
ETP Global Animal HealthThe SRA Six Themes

• Quality Assurance
• Intellectual property rights
• Overcome barriers Proof of concept
• Networks of excellence
• Education and Training
• Infrastructure

Technology transfer
1 Prioritise animal diseases
5 Regulatory Societal Issues
2 Gap Analysis
3 Fundamental research
4 Enabling Factors
6 Global Perspective
SRA
Finalised and submitted to the EU Commission in
May 2006
13
ETP Global Animal HealthImplementation of the SRA

• SRA Provides a Roadmap
• Research Requirements
• Actions to achieve Aims not all research
• Six Themes
• Recommendations Identified
• Now Identify Deliverables
• Collaboration is Critical
• Efficient Use of Resources
• Better Case for Funding

14
ETP Global Animal HealthImplementation of the SRA
Next stage
15
ETP Global Animal HealthImplementation Plan

• SRA has 2 overarching objectives-
• to deliver new and improved tools for the control
  of major diseases and
• to deliver the recommendations in the SRA

16
ETP Global Animal HealthImplementation plan

• 1. Introduction
• 2. Developing the implementation plan
• 2.1 Implementation plan
• 2.2 Deliverables
• 2.3 Structure of the plan
• 2.4 Funding
• 2.5 Consultation
• 3. Implementation Groups

17
Implementation plan Main deliverables.

• bring more focus into research towards new tools
  for dealing with animal diseases.
• increase the translation of technology into
  applications, which areefficacious in the
  control of animal disease.
• bring the developed tools faster to the market.
• remove unnecessary legal and regulatory hurdles,
  which limit diseasecontrol options and decrease
  competitiveness of the industry.
• enable disease control authorities both within
  the EU and other countries to provide a swift and
  efficient reaction to new disease outbreaks.
• streamline research, development and regulatory
  efforts in order to ensureconsumer safety
  without compromising the efficiency of the
  productdevelopment.
• view projects in the context of feasibility,
  applicability, need and availability of existing
  products within the time frame of the SRA.

18
Implementation plan How do we measure success?

• bring more focus into research towards new tools
  for dealing with animal diseases.
• increase the translation of technology into
  applications, which areefficacious in the
  control of animal disease.
• bring the developed tools faster to the market.
• remove unnecessary legal and regulatory hurdles,
  which limit diseasecontrol options and decrease
  competitiveness of the industry.
• enable disease control authorities both within
  the EU and other countries to provide a swift and
  efficient reaction to new disease outbreaks.
• streamline research, development and regulatory
  efforts in order to ensureconsumer safety
  without compromising the efficiency of the
  productdevelopment.
• view projects in the context of feasibility,
  applicability, need and availability of existing
  products within the time frame of the SRA.

19
ETP Global Animal HealthImplementation Plan

• Series of action points identified as follows-
• What is to be delivered
• How is it to be delivered
• Who is responsible for the delivery
• Who will deliver it
• How will it be funded
• What are the milestones and target dates
• What are the indicators of success
• What are the risks

20
Implementation Plan

• Establish Costs of Research
• Establish Timelines for Research
• Who should carry out Research?
• Who should Fund Research?
• Need to conduct Research on Disease
  Prioritisation Model (Chapter 2) as first step
• Need to complete Gap Analysis (Chapter 3) as
  second step

21
Implementation Plan

• At its most simplistic the format for each SRA
  recommendation could include
• Output the product of the recommendations
• Lead - The group, committee, stakeholder(S)
  with the primary responsibility for developing
  the implementation plan
• Partners the agencies or groups the lead will
  need to collaborate with in order to successfully
  deliver on the recommendations.

22
Implementation Plan
Example of action plan for a recommendation
23
(No Transcript)
24
ETP Global Animal HealthImplementation Plan

• Remember
• SRA has 2 overarching objectives-
• to deliver new and improved tools for the control
  of major diseases and
• to deliver the recommendations in the SRA

25
ETP Global Animal HealthImplementation Plan
Lisbon Agenda competitiveness
Who and how?
Major industry Players
Research Centers
Discovery
Preclinical Development
Clinical Development
Manufacture
Registration
Sales
Major diseases FMD Neglected Zoonoses
Cysticercosis Disease for Surveillance Rift
Valley Fever
26
Implementation PlanFirst Stages

• The first stage is to identify and prioritise the
  diseases of importance. The second stage is to
  assess the gaps in the knowledge and
  understanding of these diseases to identify where
  research needs to be targeted. At the same time
  the gaps in the availability of products will be
  evaluated. With the implementation of the
  recommendations from these two themes it will be
  possible to select priority diseases and identify
  the research needed to fill the gaps in knowledge
  along with the actions needed to develop new and
  improved tools for control of those diseases.

27
Implementation PlanPriorities

• Priority 1 targets that are achievable in the
  short-mid term
• Priority 2 targets that are potentially
  achievable in the mid-long term (brucellosis,
  tuberculosis, some antiparasitic vaccines, oral
  vaccination (for selected targets)
• Priority 3  Ideal World Projects  (Long-term)
  parasite vaccines, mastitis vaccines, food safety
  vaccines

28
Implementation PlanFunding

• Future EC Programs (e.g. FP7)
• Close consultation with EC, MSs, EP
  representatives
• Future national research programs
• Providing opportunities to better align and
  coordinate national programs. (ERA-Net)
• Public/private research partnerships
• Exploring areas of strategic importance in which
  ambitious initiatives can be taken

29
Implementation Plan Potential Funders
30
Implementation plan Links to EU Funding

Framework 7 Programme 2007 to 2013
Cooperation Collaborative research 32.342b
(1.944)
Ideas Frontier Research 7.460b
People Human Potential 4.728b
Capacities Research Capacity 4.243b

• Cooperation is 64 of budget of FP 7 budget of
  50.524 billion
• Food, Agriculture Biotech - 1.944b

31
Implementation PlanFunding Analysis

• Annex 6 Example Outline of funding analysis
• Analysis of potential sources of funding from the
  Commission
• Notes. Purpose of the chart is to identify
  potential funding from the EU Commission alone.
  Similar charts needed for other sources
• DG Research
• FP7 programmes
• Cooperation,
• Ideas
• People
• Capacity
• FP7 Instruments
• Collaboration/Specific Targeted Research
  Project/Integrated projects (STREP)
• Coordination Action (CA)
• Specific Support Action (SSA)
• European Research Agenda Net ERA-Net work
• International cooperation
• Other Commission Directorate Generals and
  Agencies which may have an interest.

32
(No Transcript)
33
ETP Global Animal HealthImplementation plan

• 1. Introduction
• 2. Developing the implementation plan
• 3. Implementation Groups
• 3.1 Structure
• 3.2 Implementation Group Themes 1, 2, 3
• 3.3 Implementation Group Theme 4
• 3.4 Implementation Group Theme 5
• 3.5 Other groups

34
Implementation PlanImplementation Groups

• IG1 Themes 1, 2 and 3
• IG2 Themes 4
• IG 3 Themes 5 and 6

35
Implementation PlanImplementation Group 1

• Chair
• Vice-Chair
• Members To be identified
• Secretariat Technology Platform
  Secretariat
• Aim of the Implementation Group
• To develop an implementation plan for the
  recommendations of themes 1 2 and 3 in the SRA to
  assist in enabling the Global Animal Health
  Platform to achieve the aims of the platform.
  This is to facilitate and accelerate the
  development and distribution of the most
  effective tools for controlling animal diseases
  of major importance to Europe and the rest of the
  world.

36
Implementation PlanImplementation Group 1

• Terms of Reference
• Consider how the recommendations in each of the
  themes can be implemented and establish who
  should be responsible.
• Set out the deliverables for each of the
  recommendations.
• Provide details of performance measure,
  milestones and target dates for delivery of each
  of the recommendations.
• Provide an analysis of potential cost and
  consider the strategy to acquire resources.
• Where appropriate prepare documentation to be
  used by the funding organisations as the basis
  for the calls for proposals to deliver the
  necessary research.

37
ETP Global Animal Health Governance
38
ETP Global Animal Health Governance
Steering Council
Executive board
Secretariat
Stakeholders forum
Interested Parties
25 Member States mirror groups
General Public
IG 1
IG 2
IG 3
Finance Advisory Group
39
ETP Global Animal Health Conclusions

• Action Plan to be produced following
  consultations with stakeholders and member states
  authorities. These will complement the vision
  document and the SRA.
• Need to establish Mirror groups in the Member
  States
• Identify funding sources for the implementation
  of the SRA. This will involve meetings with
  international funders and with the funding
  authorities in the EU and the member states.
• The recommendations in the SRA will need to be
  discussed with all stakeholders to identify who
  will have responsibility and ownership of the
  different components of the SRA.

40
Implementation Plan Conclusions

• Once the gap analyses have commenced the results
  will need to be reviewed by the platform in order
  to identify and make recommendations to develop
  specific diseases, technology and science
  programmes to fill the gaps.
• Once the Action Plan is completed and agreed with
  stakeholders the platform will be responsible for
  monitoring progress and undertaking an annual
  review of activities.

41
ETP Global Animal HealthUseful links for
information

• CORDIS Web Site
• http//cordis.europa.eu.int/technology-platforms/h
  ome_en.html
• CORDIS partner search http//fp6.cordis.lu/fp6/pa
  rtners.cfm
• Seventh Framework Programmehttp//europa.eu.int/
  comm/research/future/index en.cfm
• IFAH Global Animal Health Platform
• www.ifah.be/europe/euplatform/platform.htm